Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Jul-Aug;3(4):192-7.

The effect of loratadine on activated cells of the nasal mucosa in patients with allergic rhinitis

M Raptopoulou-Gigi  1 , G Ilonidis, H Orphanou-Koumerkeridou, C Preponis, J Sidiropoulos, T Lazaridis, G Goulis
Affiliations
  • PMID: 8281352
Clinical Trial

The effect of loratadine on activated cells of the nasal mucosa in patients with allergic rhinitis

M Raptopoulou-Gigi et al. J Investig Allergol Clin Immunol. 1993 Jul-Aug.

Abstract

The effect of loratadine on the numbers of activated cells--cells expressing interleukin-2 receptors(IL-2R), HLA-DR antigens and proliferating cell nuclear antigen (PCNA)--in the nasal mucosa was studied in 48 patients with allergic rhinitis. Patients were treated with either loratadine (10 mg) or placebo for 1 month. At the end of treatment, a significant decrease in the symptom scores was noted in both groups of patients. However, the clinical score was significantly lower in the loratadine group compared to the placebo group. At the end of treatment, the numbers of IL-2R+, HLA-DR+ and PCNA+ cells were significantly decreased only in the group on loratadine. An almost significant correlation was also observed between the numbers of IL-2R+ cells and symptoms in the loratadine group. Our results show that loratadine exerts its beneficial effect possibly by inhibiting both the action of histamine and immune activation.

PubMed Disclaimer

Publication types